LINGO4 is a leucine-rich repeat and immunoglobulin domain-containing protein belonging to the LINGO family of signaling receptors localized to the plasma membrane 1. The LINGO protein family includes four members (LINGO1-4), with LINGO4 showing neuronal-restricted expression during early embryonic development alongside other family members including LINGO2 1. LINGO4 forms native multimeric complexes with other LINGO homologs through physical protein-protein interactions, as demonstrated by bioluminescence resonance energy transfer and co-immunoprecipitation analyses 2. This capacity for heteromeric complex formation suggests a sophisticated regulatory mechanism in nervous system function 2. Regarding disease relevance, LINGO4 has been investigated as a potential genetic risk factor for essential tremor (ET), a common movement disorder 3. However, a genetic association study examining coding region variants (rs61746299 and rs1521179) found no significant differences between 150 Chinese Han ET patients and 300 matched controls, suggesting LINGO4 variants play little or no role in ET susceptibility 4. More recently, LINGO4 was identified among extracellular matrix-related genes significantly associated with survival outcomes in esophageal cancer patients 5, though this represents a bioinformatic finding requiring further validation. Overall, LINGO4's clinical significance remains unclear, with limited evidence supporting a major role in neurological disease susceptibility.